Retinal detachment was irreversible, but with the groundbreaking contributions of medical pioneers like Jules Gonin in the ...

Kiora Pharmaceuticals, Inc. (NASDAQ: KPRX), ("Kiora" or the "Company") announced their abstract of a preclinical study of KIO ...

Pykus Therapeutics, Inc. ("Pykus" or the "Company"), a clinical-stage medical technology company, announced today that it will present an overview of its investigational retinal sealant, PYK-2101, at ...

Every morning – shortly after checking my phone and shortly before brushing my teeth – I pull down my lower eyelids in turn ...

NY Retina, a newly launched ophthalmology practice, is set to open March 20 in a newly purchased medical office building in ...

The following is a summary of “Cystoid Macular Edema Following Rhegmatogenous Retinal Detachment Repair Surgery: Incidence, Pathogenesis, Risk Factors and Treatment,” published in the February 2025 ...

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

The Phase I/II LIGHTHOUSE trial is assessing the safety and tolerability of the gene therapy in male subjects.

But see an eye doctor as soon as possible if you have symptoms: In some cases, PVD can lead to a retinal tear or detachment, which requires immediate treatment. The vitreous can stick to the ...

New anti–vascular endothelial growth factor (VEGF) therapies are improving retinal disease management by providing patients ...